Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
45
Views
23
CrossRef citations to date
0
Altmetric
Research Article

The Role of Soluble CD23 in Distinguishing Stable and Progressive Forms of B-chronic Lymphocytic Leukemia

Josef D. Schwarzmeier Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Medhat Shehata Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Martin Hilgarth Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Ingrid Marschitz Department of Hematology and Oncology, University of Innsbruck, Internal Medicine, A-6020 Innsbruck, Austria
,
Norbert Louda Department of Hematology, Clinic of Internal Medicine I, University of Vienna
,
Rainer Hubmann L. Boltzmann Institute for Cytokine Research, University of Vienna, P.O. Box 16, Waehringer Guertel 18-20, A-1097, Vienna, Austria
&
Richard Greil Department of Hematology and Oncology, University of Innsbruck, Internal Medicine, A-6020 Innsbruck, Austria
 show all
Pages 549-554 | Published online: 01 Jul 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Karen WL Yee & Susan M O’Brien. (2006) Emerging drugs for chronic lymphocytic leukaemia. Expert Opinion on Emerging Drugs 11:1, pages 167-189.
Read now
Edgardo S Santos, Mohamad Masri & Hana Safah. (2005) Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 5:5, pages 875-891.
Read now
JD Schwarzmeier, R Hubmann, M Düchler, U Jäger & M Shehata. (2005) Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 46:2, pages 157-165.
Read now

Articles from other publishers (20)

Juan A. Piñeyroa, Laura Magnano, Andrea Rivero, Alfredo Rivas‐Delgado, Ferran Nadeu, Juan Gonzalo Correa, Eva Giné, Neus Villamor, Xavier Filella, Dolors Colomer, Mònica López, Irene López‐Oreja, Dolors Costa, Marta Aymerich, Sílvia Beà, Armando López‐Guillermo, Elías Campo, Julio Delgado & Pablo Mozas. (2022) Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia. Hematological Oncology 40:4, pages 588-595.
Crossref
Fatemeh Saberi Hosnijeh, Lina van der Straten, Arnon P. Kater, Marinus H.J. van Oers, Ward F.M. Posthuma, Martine E.D. Chamuleau, Mar Bellido, Jeanette K. Doorduijn, Michel van Gelder, Mels Hoogendoorn, Fransien de Boer, G. Doreen te Raa, J. Martijn Kerst, Erik W.A. Marijt, Reinier A.P. Raymakers, Harry R. Koene, Martijn R. Schaafsma, Johan A. Dobber, Sanne H. Tonino, Sabina S. Kersting, Anton W. Langerak & Mark-David Levin. (2020) Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study. Experimental Hematology 89, pages 55-60.e6.
Crossref
Karrie K. Wong, Fang Zhu, Ismat Khatri, Qiang Huo, David E. Spaner & Reginald M. Gorczynski. (2016) Characterization of CD200 Ectodomain Shedding. PLOS ONE 11:4, pages e0152073.
Crossref
Aaron C. Logan & David B. Miklos. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation 714 726 .
Rudolf Kaaks, Disorn Sookthai, Anna Łuczyńska, Christopher C. Oakes, Susen Becker, Theron Johnson, Annsofie Johansson, Beatrice Melin, Klas Sjöberg, Dimitrios Trichopoulos, Antonia Trichopoulou, Pagona Lagiou, Amalia Mattiello, Rosario Tumino, Giovanna Masala, Claudia Agnoli, Heiner Boeing, Krasimira Aleksandrova, Paul Brennan, Silvia Franceschi, Sandrine Roulland, Delphine Casabonne, Silvia de Sanjose, María-José Sánchez, José María Huerta, Eva Ardanaz, Nuria Sala, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Elisabete Weiderpass, H. B(as). Bueno-de-Mesquita, Roel Vermeulen, Petra H. Peeters, Paolo Vineis, Rachel S. Kelly, Kay-Tee Khaw, Ruth C. Travis, Timothy J. Key, Elio Riboli & Alexandra Nieters. (2015) Lag Times between Lymphoproliferative Disorder and Clinical Diagnosis of Chronic Lymphocytic Leukemia: A Prospective Analysis Using Plasma Soluble CD23. Cancer Epidemiology, Biomarkers & Prevention 24:3, pages 538-545.
Crossref
Barbara Platzer, Floortje Ruiter, John van der Mee & Edda Fiebiger. (2011) Soluble IgE receptors—Elements of the IgE network. Immunology Letters 141:1, pages 36-44.
Crossref
Greta Maria Paola Giordano AttianeseVirna MarinValentina HoyosBarbara SavoldoIrene PizzitolaSarah TettamantiValentina AgostoniMatteo ParmaMaurilio Ponzoni, Maria T. S. Bertilaccio, Paolo Ghia, Andrea BiondiGianpietro DottiEttore Biagi. (2011) In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor. Blood 117:18, pages 4736-4745.
Crossref
Paula Cramer & Michael Hallek. (2010) Prognostic factors in chronic lymphocytic leukemia—what do we need to know?. Nature Reviews Clinical Oncology 8:1, pages 38-47.
Crossref
Ningyan Zhang, Brent R. Williams, Ping Lu, Zhiqiang An & Chen-Ni Chin. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies 711 762 .
Pauline N. M. Mwinzi, Lisa Ganley‐Leal, Carla L. Black, W. Evan Secor, Diana M. S. Karanja & Daniel G. Colley. (2009) Circulating CD23 + B Cell Subset Correlates with the Development of Resistance to Schistosoma mansoni Reinfection in Occupationally Exposed Adults Who Have Undergone Multiple Treatments . The Journal of Infectious Diseases 199:2, pages 272-279.
Crossref
N Meuleman, B Stamatopoulos, M Dejeneffe, H El Housni, L Lagneaux & D Bron. (2008) Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia 22:10, pages 1882-1890.
Crossref
Kedar V. Inamdar & Carlos E. Bueso-Ramos. (2007) Pathology of chronic lymphocytic leukemia: an update. Annals of Diagnostic Pathology 11:5, pages 363-389.
Crossref
B SAKA, M AKTAN, U SAMI, D ONER, O SANEM & G DINCOL. (2006) Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia. Clinical and Laboratory Haematology 28:1, pages 30-35.
Crossref
Klabusay Martin, Kohutova Viera, Coupek Petr, Nenickova Marie & Tesarova Eva. (2006) Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique andof probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors. Mediators of Inflammation 2006, pages 1-7.
Crossref
Heesoon Chang, Yousang Gwack, Dior Kingston, John Souvlis, Xiaozhen Liang, Robert E. Means, Ethel Cesarman, Lindsey Hutt-Fletcher & Jae U. Jung. (2005) Activation of CD21 and CD23 Gene Expression by Kaposi's Sarcoma-Associated Herpesvirus RTA. Journal of Virology 79:8, pages 4651-4663.
Crossref
Gudmundur RunarssonAnquan LiuYilmaz MahshidStina FeltenmarkAnnika PetterssonEva KleinMagnus BjörkholmHans-Erik Claesson. (2005) Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells. Blood 105:3, pages 1274-1279.
Crossref
S. Paneesha & D. W. Milligan. (2005) Stem cell transplantation for chronic lymphocytic leukaemia. British Journal of Haematology 128:2, pages 145-152.
Crossref
D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes & D. Milligan. (2004) Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. British Journal of Haematology 125:3, pages 294-317.
Crossref
Heather DeGrendele, Angelia D. Gibson, Mary Hightower & Vinay K. Jain. (2003) Highlights From: 44th Annual Meeting of the American Society of Hematology;December 7-10, 2002 Philadelphia, Pennsylvania. Clinical Lymphoma 4:1, pages 10-15.
Crossref
Peter H. Wiernik. 2003. 365 397 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.